BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11555022)

  • 1. Calcium phosphate crystal-associated proteins: alpha-2-HS-glycoprotein, prothrombin fragment 1 and osteopontin.
    Nishio S; Hatanaka M; Takeda H; Aoki K; Iseda T; Iwata H; Yokoyama M
    Int J Urol; 2001 Aug; 8(8):S58-62. PubMed ID: 11555022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin.
    Nishio S; Hatanaka M; Takeda H; Aoki K; Iseda T; Iwata H; Yokoyama M
    Mol Urol; 2000; 4(4):383-90. PubMed ID: 11156706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of calcium phosphate-associated proteins on calcium oxalate crystallization: alpha2-HS-glycoprotein, prothrombin-F1 and osteopontin.
    Nishio S; Iseda T; Takeda H; Iwata H; Yokoyama M
    BJU Int; 2000 Sep; 86(4):543-8. PubMed ID: 10971289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of urinary concentrations of calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin.
    Nishio S; Hatanaka M; Takeda H; Iseda T; Iwata H; Yokoyama M
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S394-6. PubMed ID: 10541271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects.
    Atmani F; Glenton PA; Khan SR
    Urol Res; 1998; 26(3):201-7. PubMed ID: 9694603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of proteins that inhibit calcium oxalate crystallization in vitro in the urine of normal and stone-forming individuals.
    Hedgepeth RC; Yang L; Resnick MI; Marengo SR
    Am J Kidney Dis; 2001 Jan; 37(1):104-112. PubMed ID: 11136174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
    Kumar V; Farell G; Lieske JC
    J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation.
    Webber D; Radcliffe CM; Royle L; Tobiasen G; Merry AH; Rodgers AL; Sturrock ED; Wormald MR; Harvey DJ; Dwek RA; Rudd PM
    FEBS J; 2006 Jul; 273(13):3024-37. PubMed ID: 16817853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of warfarin therapy on the charge properties of urinary prothrombin fragment 1 and crystallization of calcium oxalate in undiluted human urine.
    Buchholz NP; Kim DS; Grover PK; Dawson CJ; Ryall RL
    J Bone Miner Res; 1999 Jun; 14(6):1003-12. PubMed ID: 10352110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity.
    Grover PK; Ryall RL
    Eur J Biochem; 1999 Jul; 263(1):50-6. PubMed ID: 10429186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of urinary prothrombin fragment 1 in the formation of calcium oxalate calculus.
    Liu J; Chen J; Wang T; Wang S; Ye Z
    J Urol; 2005 Jan; 173(1):113-6. PubMed ID: 15592049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hole truth: intracrystalline proteins and calcium oxalate kidney stones.
    Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR
    Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human and rat urine.
    Atmani F; Opalko FJ; Khan SR
    Urol Res; 1996; 24(1):45-50. PubMed ID: 8966841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of growth and aggregation of calcium oxalate crystals in vitro--a comparison of four human proteins.
    Grover PK; Moritz RL; Simpson RJ; Ryall RL
    Eur J Biochem; 1998 May; 253(3):637-44. PubMed ID: 9654060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin.
    Stapleton AM; Ryall RL
    Br J Urol; 1995 Jun; 75(6):712-9. PubMed ID: 7613825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of osteopontin in the urine of healthy and stone-forming men.
    Yasui T; Fujita K; Hayashi Y; Ueda K; Kon S; Maeda M; Uede T; Kohri K
    Urol Res; 1999 Aug; 27(4):225-30. PubMed ID: 10460890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Face-specific binding of prothrombin fragment 1 and human serum albumin to inorganic and urinary calcium oxalate monohydrate crystals.
    Cook AF; Grover PK; Ryall RL
    BJU Int; 2009 Mar; 103(6):826-35. PubMed ID: 19021614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of osteopontin on calcium oxalate crystal formation.
    Konya E; Umekawa T; Iguchi M; Kurita T
    Eur Urol; 2003 May; 43(5):564-71. PubMed ID: 12706004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.